Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Proton Therapy × Breast × Clear all

Phase

Status

Sponsor Class

OTHER 5 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 CNS 2 Tumor-Agnostic 1 Sarcoma 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 37 Docetaxel 29 Paclitaxel 26 Doxorubicin 24 Trastuzumab 23 Tamoxifen 23 Radiotherapy 18 Epirubicin 13 Letrozole 11 Fluorouracil 9 Lapatinib 8 Capecitabine 8 Bevacizumab 8 Anastrozole 8 exemestane 7 Immunohistochemistry 7 Gene Expression Profiling 7 Filgrastim 7 Zoledronic Acid 6 Surgical Procedures, Operative 6 Methotrexate 6 Magnetic Resonance Spectroscopy 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 palbociclib 5 Microarray Analysis 5 Carboplatin 5 Absorptiometry, Photon 5 pertuzumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05856773 2025-09-09

COMPRO

Proton Collaborative Group

Phase 3 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡